Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2m. Reported cases of notifiable diseases, by region and reporting area - - United States and U.S. territories, 2017
Reporting Area Shiga toxin-producing Escherichia coli * Shigellosis Smallpox Spotted fever rickettsiosis Streptococcal toxic shock syndrome
Total Confirmed Probable
United States 8,672 14,912 — 6,248 176 6,072 372
New England 325 349 — 82 — 82 54
Connecticut 74 78 — 7 — 7 22
Maine 34 13 — 3 — 3 13
Massachusetts 137 185 — 42 — 42 10
New Hampshire 43 12 — 11 — 11 —
Rhode Island 14 44 — 15 — 15 6
Vermont 23 17 — 4 — 4 3
Middle Atlantic 674 1,346 — 203 3 200 33
New Jersey 128 338 — 137 2 135 12
New York (excluding New York City) 231 286 — 36 1 35 18
New York City 115 453 — 2 — 2 —
Pennsylvania 200 269 — 28 — 28 3
East North Central 981 1,873 — 292 4 288 113
Illinois 212 361 — 127 1 126 82
Indiana 118 153 — 94 2 92 21
Michigan 149 458 — 13 — 13 2
Ohio 280 634 — 35 1 34 8
Wisconsin 222 267 — 23 — 23 —
West North Central 1,520 1,033 — 879 16 863 14
Iowa 276 174 — 17 — 17 N
Kansas 139 228 — 218 2 216 —
Minnesota 531 145 — 13 — 13 11
Missouri 292 424 — 579 10 569 3
Nebraska 151 31 — 25 2 23 —
North Dakota 40 2 — 14 — 14 —
South Dakota 91 29 — 13 2 11 —
South Atlantic 756 2,991 — 1,139 88 1,051 70
Delaware 11 33 — 41 2 39 —
District of Columbia 9 67 — 4 1 3 —
Florida 187 1,307 — 25 2 23 N
Georgia 138 403 — 71 71 — 24
Maryland 81 239 — 61 — 61 —
North Carolina 81 294 — 518 6 512 22
South Carolina 42 415 — 94 3 91 2
Virginia 179 207 — 307 2 305 21
West Virginia 28 26 — 18 1 17 1
East South Central 303 1,014 — 1,869 13 1,856 15
Alabama 30 247 — 671 6 665 N
Kentucky 59 275 — 250 1 249 12
Mississippi 29 184 — 170 — 170 N
Tennessee 185 308 — 778 6 772 3
West South Central 1,367 2,181 — 1,686 25 1,661 —
Arkansas 86 249 — 1,214 6 1,208 —
Louisiana 41 259 — 22 — 22 —
Oklahoma 109 151 — 349 16 333 N
Texas 1,131 1,522 — 101 3 98 N
Mountain 925 1,056 — 77 26 51 73
Arizona 166 555 — 31 21 10 —
Colorado 274 176 — 10 1 9 5
Idaho 133 36 — 3 1 2 5
Montana 97 10 — 11 2 9 3
Nevada 49 98 — 3 — 3 27
New Mexico 42 131 — 3 — 3 —
Utah 140 44 — 10 — 10 31
Wyoming 24 6 — 6 1 5 2
Pacific 1,821 3,069 — 21 1 20 —
Alaska 11 6 — N N N N
California 1,288 2,613 — 12 — 12 N
Hawaii 19 38 — N N N —
Oregon 211 127 — 4 1 3 N
Washington 292 285 — 5 — 5 N
Territories 3 36 — — — — —
American Samoa — — — N N N N
Commonwealth of Northern Mariana Islands — — — — — — —
Guam — 16 — N N N —
Puerto Rico 3 20 — N N N N
U.S. Virgin Islands — — — — — — —
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * Includes Escherichia coli O157:H7 and Shiga toxin-positive Escherichia coli (including O157, non-O157, and not serogrouped).
Notes:
  • These are annual cases of selected infectious national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published. Cases are reported by state health departments to CDC weekly. Because source datasets may be updated as additional information is received, statistics in publications based on that source data may differ from what is presented in these tables.
  • The list of nationally notifiable infectious diseases and conditions for 2018 and their national surveillance case definitions are available by navigating to the Surveillance Case Definitions | CDC web page, selecting "2017" for the notifiable condition list year, checking "infectious" conditions, and clicking "Get Notifiable List by Year". This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved in 2016 by CSTE for national surveillance, that were implemented in January 2017, including updated surveillance case definitions for salmonellosis, shigellosis, vibrioisis, perinatal hepatitis B virus infection, invasive pneumococcal disease, Lyme disease, and tularemia reported through August 7, 2018. Publication criteria for the finalized 2017 data are available at https://wonder.cdc.gov/nndss/documents/2017_NNDSS_Publication_Criteria.pdf. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Population estimates for incidence rates are July 1st, 2017 estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for April 1, 2010 - July 1, 2017, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino), and sex (Vintage 2017), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states released June 27, 2018 are available at https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Population estimates for territories are the 2017 mid-year estimates from the U.S. Census Bureau International Data Base, accessed on October 2, 2018 at https://www.census.gov/data-tools/demo/idb/informationGateway.php. The choice of population denominators for incidence is based on the availability of population data at the time of publication preparation.
  • Annual tables for 2016 and later years are available on CDC WONDER.
  • Annual summary reports from 1993-2015 are available as published in the MMWR.
  • NNDSS annual tables since 1952 are available at CDC Stacks (once in CDC Stacks select "Annual Reports" in the "Genre" box to the left).
Suggested Citation: